C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2011
10/13/2011	US20110252509 Method for Producing a Transgenic Cell with Increased Gamma-Aminobutyric Acid (Gaba) Content
10/13/2011	US20110252508 Plants Having Enhanced Yield-Related Traits and/or Abiotic Stress Tolerance and a Method for Making the Same
10/13/2011	US20110252507 Transgenic plants used as a bioreactor system
10/13/2011	US20110252505 Down-Regulation of ACC Synthase for Improved Plant Performance
10/13/2011	US20110252504 Promoter From Z. Mais
10/13/2011	US20110252503 Plants With Improved Nitrogen Utilization and Stress Tolerance
10/13/2011	US20110252502 Grg23 epsp synthases: compositions and methods of use
10/13/2011	US20110252501 Transgenic plants with enhanced agronomic traits
10/13/2011	US20110252497 Soybean Cultivar S090244
10/13/2011	US20110252496 Soybean Cultivar 86237173
10/13/2011	US20110252494 Soybean Cultivar S090247
10/13/2011	US20110252492 Soybean cultivar 8029288
10/13/2011	US20110252491 Chimeric plant promoters and their uses in plants
10/13/2011	US20110252489 Method of identifying prolificacy in mammals
10/13/2011	US20110252487 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same
10/13/2011	US20110252486 Chondrocyte-like cell, and method for producing same
10/13/2011	US20110251593 In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs
10/13/2011	US20110251376 Mammalian Tumor Susceptibility Genes and their Uses
10/13/2011	US20110251267 Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factor
10/13/2011	US20110251263 RNAi Modulation of the BCR-ABL Fusion Gene and Uses Thereof
10/13/2011	US20110251262 Compositions And Methods For Inhibiting Expression Of An RNA From West Nile Virus
10/13/2011	US20110251259 Compositions and methods for inhibiting expression of cd274/pd-l1 gene
10/13/2011	US20110251257 Methods and compositions for treating neurological disease
10/13/2011	US20110251246 Small molecule inhibitors of muc1 and methods of identifying the same
10/13/2011	US20110251216 Compositions and methods for inhibiting ezh2
10/13/2011	US20110251189 Hypoxia targeted compounds for cancer diagnosis and therapy
10/13/2011	US20110251156 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
10/13/2011	US20110251138 Lipoic acid metabolite conjugate: preparation and their therapeutic effect
10/13/2011	US20110251133 Blockade of gamma-secretase activity to promote myelination by oligodendrocytes
10/13/2011	US20110251130 Methods and Compositions for Promoting Bone Growth
10/13/2011	US20110251128 THYMOSIN Beta4 PEPTIDES PROMOTE TISSUE REGENERATION
10/13/2011	US20110251122 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
10/13/2011	US20110251108 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/13/2011	US20110250693 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
10/13/2011	US20110250692 Method for producing induced pluripotent stem cells
10/13/2011	US20110250691 Culture medium for myoblasts, precursors thereof and derivatives thereof
10/13/2011	US20110250690 Microfluidic Embryo and Gamete Culture Systems
10/13/2011	US20110250689 Multilayer preform obtained by electro-spinning, method for producing a preform as well as use thereof
10/13/2011	US20110250688 Three Dimensional Tissue Generation
10/13/2011	US20110250687 Cell adhesion inhibitor (CAI) with combination growth factors mobilization of peripheral blood mononuclear cells for CAI derived dendritic cell (CdDC) preparation and dendritic cell vaccine preparations generated from CdDC
10/13/2011	US20110250686 NOVEL HEPATOCYTE-LIKE CELLS AND HEPATOBLAST-LIKE CELLS DERIVED FROM hBS CELLS
10/13/2011	US20110250685 Compositions and methods for enhancing cellular transport of biomolecules
10/13/2011	US20110250684 Method for producing neural stem cells
10/13/2011	US20110250683 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
10/13/2011	US20110250682 Formation of neuromuscular junctions in a defined system
10/13/2011	US20110250681 Fc Variants with Optimized Properties
10/13/2011	US20110250680 Automated system for the lysis of microorganisms present in a sample, for extraction and for purification of the nucleic acids of said microorganisms for purposes of analysis
10/13/2011	US20110250679 Methods and Compositions for High-Resolution Micropatterning for Cell Culture
10/13/2011	US20110250675 Virus-Like Particle Mediated Cellular Delivery
10/13/2011	US20110250669 Method and apparatus for selectively targeting specific cells within a cell population
10/13/2011	US20110250650 Lentiviral vectors for the preparation of immunotherapeutical compositions
10/13/2011	US20110250644 Feed supplement for mammalian cell culture and methods of use
10/13/2011	US20110250643 Antibody composition-producing cell
10/13/2011	US20110250640 Method of recloning production cells
10/13/2011	US20110250632 Methods for conducting cellular assays
10/13/2011	US20110250631 Proteoglycan degrading mutants for treatment of cns
10/13/2011	US20110250630 Motif-grafted hybrid polypeptides and uses thereof
10/13/2011	US20110250628 Hcv replicons containing ns5b from genotype 2b
10/13/2011	US20110250620 Methods of evaluating an immune response to an antigen
10/13/2011	US20110250609 Methods For The Detection, Analysis And Isolation Of Nascent Proteins
10/13/2011	US20110250590 Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
10/13/2011	US20110250345 Soybean Cultivar S090252
10/13/2011	US20110250342 PUFA Polyketide Synthase Systems and Uses Thereof
10/13/2011	US20110250300 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
10/13/2011	US20110250280 Microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type i diabetes mellitus
10/13/2011	US20110250263 Protein and nucleic acid delivery vehicles, components and mechanisms thereof
10/13/2011	US20110250236 Stem cells derived from the carotid body and uses thereof
10/13/2011	US20110250232 DNA-Transfection System for the Generation of Infectious Influenza Virus
10/13/2011	US20110250230 Cell capable of expressing exogenous gitr ligand
10/13/2011	US20110250221 Group A Streptococcus Pharmaceutical Compositions and Methods Thereof
10/13/2011	US20110250219 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
10/13/2011	US20110250211 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
10/13/2011	US20110250210 Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1)
10/13/2011	US20110250207 Anti-fxi antibodies and methods of use
10/13/2011	US20110250204 Methods and compositions for diagnosing and treating diseases
10/13/2011	US20110250203 Anti-cd5 antibodies
10/13/2011	US20110250202 Reagents, methods, and systems for detecting methicillin-resistant staphylococcus
10/13/2011	US20110250199 Immunotoxins and uses thereof
10/13/2011	US20110250195 Antibodies Against IL-25
10/13/2011	US20110250188 LCMV-GP-VSV-Pseudotyped Vectors and Tumor-Infiltrating Virus-Producing Cells for the Therapy of Tumors
10/13/2011	US20110250185 Tumor suppression using placental stem cells
10/13/2011	US20110250182 Angiogenesis using placental stem cells
10/13/2011	US20110250181 Human lysosomal proteins from plant cell culture
10/13/2011	US20110250175 Tlr7 ligand and uses thereof
10/13/2011	US20110250168 Sialoadhesin-related compositions and methods
10/13/2011	US20110250130 Tnf-alpha binding proteins
10/13/2011	CA2828315A1 Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof
10/13/2011	CA2795938A1 Compositions and methods for providing hematopoietic function
10/13/2011	CA2795831A1 Method for the generation of monoclonal antibodies derived from human b cells
10/13/2011	CA2795789A1 Btnl9 proteins, nucleic acids, and antibodies and uses thereof
10/13/2011	CA2795686A1 Biocompatible poly(amic acid) and method of preparation thereof
10/13/2011	CA2795627A1 Compositions and methods for providing hematopoietic function without hla matching
10/13/2011	CA2795562A1 Secretome profile-facilitated in vitro fertilization
10/13/2011	CA2795534A1 Cdca5 peptides and vaccines including the same
10/13/2011	CA2795518A1 Angiogenesis using placental stem cells
10/13/2011	CA2795498A1 Cell poration
10/13/2011	CA2795423A1 Cluap1 peptides and vaccines including the same
10/13/2011	CA2795200A1 Soluble human st-2 antibodies and assays
10/13/2011	CA2795040A1 Buffy coat separator float systems and methods
10/13/2011	CA2795031A1 Method for culturing cells in a system comprising laminin-5

1 ... 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 ... 1827